Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 79% ± 17% | |
oligodendrocyte | 11 studies | 37% ± 18% | |
smooth muscle cell | 10 studies | 48% ± 22% | |
GABAergic neuron | 9 studies | 65% ± 24% | |
pericyte | 9 studies | 37% ± 27% | |
fibroblast | 9 studies | 43% ± 22% | |
neuron | 7 studies | 36% ± 19% | |
microglial cell | 7 studies | 32% ± 20% | |
retinal ganglion cell | 7 studies | 64% ± 29% | |
endothelial cell | 6 studies | 52% ± 21% | |
interneuron | 6 studies | 49% ± 27% | |
cardiac muscle cell | 6 studies | 93% ± 10% | |
mesothelial cell | 6 studies | 35% ± 6% | |
retinal bipolar neuron | 5 studies | 45% ± 31% | |
granule cell | 4 studies | 75% ± 25% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 15% | |
OFF-bipolar cell | 4 studies | 57% ± 31% | |
ON-bipolar cell | 4 studies | 60% ± 28% | |
amacrine cell | 4 studies | 41% ± 23% | |
astrocyte | 4 studies | 42% ± 27% | |
GABAergic interneuron | 3 studies | 65% ± 7% | |
Purkinje cell | 3 studies | 58% ± 30% | |
macrophage | 3 studies | 23% ± 6% | |
GABAergic amacrine cell | 3 studies | 43% ± 19% | |
glycinergic amacrine cell | 3 studies | 52% ± 26% | |
rod bipolar cell | 3 studies | 75% ± 31% | |
adipocyte | 3 studies | 47% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 56% | 1223.93 | 136 / 245 | 74% | 3.38 | 372 / 502 |
brain | 80% | 4696.70 | 2116 / 2642 | 41% | 2.32 | 288 / 705 |
thymus | 86% | 2228.20 | 562 / 653 | 30% | 1.01 | 179 / 605 |
lung | 89% | 1882.91 | 512 / 578 | 26% | 0.82 | 300 / 1155 |
pancreas | 79% | 1253.05 | 258 / 328 | 30% | 0.71 | 54 / 178 |
ovary | 83% | 1881.54 | 150 / 180 | 23% | 0.60 | 101 / 430 |
blood vessel | 99% | 6378.19 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 58674.50 | 852 / 861 | 0% | 0 | 0 / 0 |
esophagus | 62% | 3209.00 | 902 / 1445 | 31% | 1.31 | 57 / 183 |
stomach | 41% | 1201.92 | 148 / 359 | 31% | 1.03 | 89 / 286 |
intestine | 51% | 1191.27 | 491 / 966 | 20% | 0.59 | 107 / 527 |
bladder | 52% | 1032.76 | 11 / 21 | 15% | 0.36 | 74 / 504 |
adrenal gland | 2% | 25.53 | 5 / 258 | 54% | 2.97 | 125 / 230 |
uterus | 27% | 378.31 | 46 / 170 | 15% | 0.51 | 67 / 459 |
spleen | 31% | 429.29 | 75 / 241 | 0% | 0 | 0 / 0 |
breast | 22% | 512.68 | 100 / 459 | 9% | 0.35 | 103 / 1118 |
skin | 2% | 33.69 | 40 / 1809 | 22% | 1.04 | 103 / 472 |
adipose | 21% | 397.89 | 257 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 14% | 0.44 | 127 / 901 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.58 | 3 / 29 |
liver | 0% | 0 | 0 / 226 | 8% | 0.34 | 31 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
muscle | 1% | 12.74 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0098907 | Biological process | regulation of SA node cell action potential |
GO_0098910 | Biological process | regulation of atrial cardiac muscle cell action potential |
GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
GO_0006941 | Biological process | striated muscle contraction |
GO_0035994 | Biological process | response to muscle stretch |
GO_0086029 | Biological process | Purkinje myocyte to ventricular cardiac muscle cell signaling |
GO_0010882 | Biological process | regulation of cardiac muscle contraction by calcium ion signaling |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0070296 | Biological process | sarcoplasmic reticulum calcium ion transport |
GO_0086064 | Biological process | cell communication by electrical coupling involved in cardiac conduction |
GO_0098904 | Biological process | regulation of AV node cell action potential |
GO_0086005 | Biological process | ventricular cardiac muscle cell action potential |
GO_0071872 | Biological process | cellular response to epinephrine stimulus |
GO_0002027 | Biological process | regulation of heart rate |
GO_0003300 | Biological process | cardiac muscle hypertrophy |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0014850 | Biological process | response to muscle activity |
GO_0010881 | Biological process | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion |
GO_0097050 | Biological process | type B pancreatic cell apoptotic process |
GO_0051775 | Biological process | response to redox state |
GO_0003220 | Biological process | left ventricular cardiac muscle tissue morphogenesis |
GO_0051284 | Biological process | positive regulation of sequestering of calcium ion |
GO_0001666 | Biological process | response to hypoxia |
GO_0071313 | Biological process | cellular response to caffeine |
GO_0060402 | Biological process | calcium ion transport into cytosol |
GO_0098911 | Biological process | regulation of ventricular cardiac muscle cell action potential |
GO_0098735 | Biological process | positive regulation of the force of heart contraction |
GO_0014808 | Biological process | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO_0031000 | Biological process | response to caffeine |
GO_0055117 | Biological process | regulation of cardiac muscle contraction |
GO_0006816 | Biological process | calcium ion transport |
GO_0072599 | Biological process | establishment of protein localization to endoplasmic reticulum |
GO_0010460 | Biological process | positive regulation of heart rate |
GO_0005513 | Biological process | detection of calcium ion |
GO_0003143 | Biological process | embryonic heart tube morphogenesis |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030018 | Cellular component | Z disc |
GO_0005790 | Cellular component | smooth endoplasmic reticulum |
GO_0032991 | Cellular component | protein-containing complex |
GO_0042383 | Cellular component | sarcolemma |
GO_0014701 | Cellular component | junctional sarcoplasmic reticulum membrane |
GO_0034704 | Cellular component | calcium channel complex |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0033017 | Cellular component | sarcoplasmic reticulum membrane |
GO_0048763 | Molecular function | calcium-induced calcium release activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0034237 | Molecular function | protein kinase A regulatory subunit binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0043924 | Molecular function | suramin binding |
GO_0034236 | Molecular function | protein kinase A catalytic subunit binding |
GO_0005219 | Molecular function | ryanodine-sensitive calcium-release channel activity |
GO_0015278 | Molecular function | intracellularly gated calcium channel activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | RYR2 |
Protein name | Ryanodine receptor 2 (RYR-2) (RyR2) (hRYR-2) (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor) Ryanodine receptor 2 Alternative protein RYR2 |
Synonyms | |
Description | FUNCTION: Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) cytosolic levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development. . |
Accessions | ENST00000659194.3 A0A590UJZ8 ENST00000366574.7 [Q92736-1] ENST00000609119.2 L8E9M2 Q92736 A0A590UJF6 ENST00000660292.2 A0A590UKB7 ENST00000661330.1 A0A590UK06 |